Effects of oxidized regenerated cellulose on the expression of extracellular matrix and transforming growth factor-β1 in human peritoneal fibroblasts and mesothelial cells

American Journal of Obstetrics and Gynecology

Volumn 189, Issue 6, 2003, Pages 1620-1625

  Gago, L April ^a   Saed, Ghassan M ^a   Wang, Rona X ^a   Kruger, Michael ^a   Diamond, Michael P ^a   Kenton, Kimberly ^b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Div Repro Endocrinol Infertility ^*

Author keywords

Adhesion; Extracellular matrix; Fibroblast; Mesothelial cell; Oxidized regenerated cellulose; Transforming growth factor 1

Indexed keywords

BETA ACTIN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; COMPLEMENTARY DNA; FIBRONECTIN; MESSENGER RNA; OXIDIZED REGENERATED CELLULOSE; TRANSFORMING GROWTH FACTOR BETA1;

ADHESION; CONFERENCE PAPER; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FIBROBLAST; GENE EXPRESSION; HUMAN; HUMAN CELL; MESOTHELIUM CELL; NUCLEOTIDE SEQUENCE; PERITONEUM; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0346727270     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2003.08.018     Document Type: Conference Paper

References (35)

1. Ellis H. The clinical significance of adhesions: focus on intestinal obstruction. Eur J Surg 1997;577(Suppl):5-9.
2. Daniell IF. Laparoscopic enterolysis for chronic abdominal pain. J Gynecol Surg 1989;5:61-6.
3. Steege JF, Stout AL. Resolution of chronic pelvic pain after laparoscopic lysis of adhesions. Am J Obstet Gynecol 1991;165:278-283.
4. Caspi E, Halperin Y, Bukovsky I. The importance of peri-adnexal adhesions in tubal reconstructive surgery for infertility. Fertil Steril 1979;31:296-300.
5. Shlaff WD, Hassiakos DK, Damewood MD, Rock JA. Neosalpingostomy for distal tubal obstruction: prognostic factors and impact of surgical technique. Fertil Steril 1990;54:984-90.
6. van der Krabben AA, Dijk FR, Nieuwenhuijzen M, Reijnen MM, Schaapveld M, van Goor H. Morbidity and mortality of inadvertent enterotomy during adhesiotomy. Br J Surg 2000;87:467-71.
7. Ikeda K, Yamauchi D, Osamura N, Hagiwara N, Tomita K. Hyaluronic acid prevents peripheral nerve adhesion. Br J Plast Surg 2003;56:342-7.
8. Diamond MP. Prevention of adhesions. In: Gershensopn DM, DeCherney AH, editors. Operative gynecology. 2nd Philadelphia: Saunders; 2001. p. 211-22.
9. Diamond MP, DeCherney AH. Pathogenesis of adhesion formation/reformation: application to reproductive pelvic surgery. Microsurgery 1987;8:103-7.
10. Diamond MP, Daniell JF, Feste J, Surrey MW, McLaughlin DS, Friedman S. Pelvic adhesions at early second-look laparoscopy following carbon dioxide laser surgery. Infertility 1984;7:39-44.
11. Weibel MA, Majo G. Peritoneal adhesions and their relation to abdominal surgery: a postmortem study. Am J Surg 1973;126:345-53.
12. Ray NF, Denton WG, Thamer M, Henderson S, Perry S. Abdominal adhesioloysis: inpatient care and expenditures in the United States in 1994. J Am Coll Surg 1998;186:1-9.
13. Ray NF, Larsen JW, Jr, Stillman RJ, Jacobs J. Economic impact of hospitalizations for lower abdominal adhesiolysis in the United States in 1988. Surg Gynecol Obstet 1993;176:271-6.
14. Linsky CB, Diamond MP, Cunningham T, Constantine B, DeCherney AH, diZerega GA. Adhesion reduction in a rabbit uterine horn model using TC-7. J Reprod Med 1987;32:17-20.
15. Habara T, Naktsuka M, Konishi H, Asagiri K, Nogachi S, Kudo T. The biological effects of antiadhesion agents on activated TAW 264.7 macrophages. Wiley InterScience online, June 2002. Available from: www.intersciene.wiley.com. Accessed on July 26, 2002.
16. Reddy S, Santanam N, Reddy PP, Rock JA, Murphy AA, Parthasarathy S. Interaction of Interceed oxidized regenerated cellulose with macrophages: a potential mechanism by which Interceed may prevent adhesions. Am J Obstet Gynecol 1997;177:1315-21.
17. Saed GM, Zhang W, Diamond MP. Molecular characterization of fibroblasts isolated from human peritoneum and adhesion. Fertil Steril 2001;75:762-8.
18. Saed GM, Zhang W, Chigini N, Holmdahl L, Diamond MP. Alterations in type I and III collagen expression in human peritoneal mesothelial cells in response to hypoxia and transforming growth factor-beta. Wound Repair Regen 1999;7:504-10.
19. Diamond MP, Linsky CB, Cunningham T, Kamp L, Pines E, DeCherney AH, et al. Synergistic effects of Interceed (TC-7) and heparin in reducing adhesion formation in the rabbit uterine horn model. Fertil Steril 1991;55:389-94.
20. Diamond MP, Linsky CB, Cunningham T, Kamp L, Pines E, DeCherney AH, et al. Adhesion reformation: reduction by the use of Interceed (TC-7) plus heparin. J Gynecol Surg 1991;7:1-6.
21. Diamond MP, Linsky CB, Cunningham T, Constantine B, diZerega G, DeCherney AH. A model for sidewall adhesions in the rabbit: reduction by an absorbable barrier. Microsurgery 1987;8:197-200.
22. Wiseman DM, Gottlick LE, Diamond MP. Effect of thrombin induced hemostasis on the efficacy of an absorbable adhesion barrier. J Reprod Med 1992;37:766-70.
23. Marana R, Catalano GF, Caruana P, Margutti F, Muzli L, Mancuso S. Postoperative adhesion formation and reproductive outcome using Interceed after ovarian surgery: a randomized trial in the rabbit model. Hum Reprod 1997;12:1935-8.
24. Wiseman DM, Trout JR, Franklin RK, Diamond MP. Metaanalysis of the safety and efficacy of an adhesion barrier (Interceed TC7) in laparotomy. J Reprod Med 1999;44:325-31.
25. Interceed (TC7) Adhesion Barrier Study Group. Prevention of postsurgical adhesion by Interceed (TC7), an absorbable adhesion barrier: a prospective randomized multicenter clinical study. Fertil Steril 1989;51:933-8.
26. Sekiba K. Obstetrics and Gynecology Adhesion Prevention Committee: use of Interceed (TC7) absorbable adhesion barrier to reduce postoperative adhesion reformation in infertility and endometriosis surgery. Obstet Gynecol 1992;79:518-22.
27. Azziz R. Interceed (TC7) Adhesion Barrier Study Group:II, microsurgery alone or with Interceed absorbable adhesion barrier for pelvic sidewall adhesion reformation. Surg Gynecol Obstet 1993;177:135-9.
28. Franklin RR. Ovarian Adhesion Study Group: reduction of ovarian adhesions by the use of Interceed. Obstet Gynecol 1995;86(3):335-40.
29. Sawada T, Nishizawa H, Nishio E, Kadowaki M. Postoperative adhesion prevention with an oxidized regenerated cellulose adhesion barrier in infertile women. J Reprod Med 2000;45:387-9.
30. Saed GM, Diamond MP. Modulation of the expression of tissue plasminogen activator and its inhibitor by hypoxia in human peritoneal and adhesion fibroblasts. Fertil Steril 2003;70:164-8.
31. Sporn MB, Roberts AB. Transforming growth factor-13, multiple actions and potential clinical applications. JAMA 1989;262:938-941.
32. Freeman M, Saed GM, Elhammady E, Diamond MP. Expression of transforming growth factor beta isoform mRNA in injured peritoneum healing with adhesions, without adhesions, and in uninjured peritoneum. Fertil Steril 2003;80(Suppl):708-13.
33. Chegini N. The Role of growth factors in peritoneal healing: transforming growth factor 13 (TGF-β). Eur J Surg 1997;577(Suppl):17-23.
34. Chegini N, Kotseos K, Zhao Y, Bennet B, McLean FW, Diamond MP, et al. Differential expression of TGF-β1 and TGF-β3 in serosal tissues of human intraperitoneal organs and peritoneal adhesions. Hum Reprod 2001;16:1291-300.
35. Assoian RK, Sporn MB. Type-beta transforming growth factor in human platelets: release during platelet degranulation and action on vascular smooth muscle cells. J Cell Biol 1986;102:1217-23.